United States · Platforms & data · Benzinga
Why is Aclaris Therapeutics Stock Trading Lower on Monday?

Detailed summary
Aclaris Therapeutics Inc. (NASDAQ:ACRS) CEO Neal Walker affirmed on Monday that the clinical-stage biopharmaceutical company will maintain its core development priorities despite…
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.benzinga.com)




